Filing Details

Accession Number:
0001237899-11-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-07 17:57:08
Reporting Period:
2011-09-02
Filing Date:
2011-09-07
Accepted Time:
2011-09-07 17:57:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1487767 S Michael Aberman 777 Old Saw Mill River Road
Tarrytown NY 10591
Vp Strategy And Investor Relat No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-02 4,166 $24.00 14,166 No 4 M Direct
Common Stock Disposition 2011-09-02 4,166 $64.00 10,000 No 4 S Direct
Common Stock Acquisiton 2011-09-06 8,334 $24.00 18,334 No 4 M Direct
Common Stock Disposition 2011-09-06 3,041 $65.76 15,293 No 4 F Direct
Common Stock Disposition 2011-09-06 1,916 $65.76 13,377 No 4 F Direct
Common Stock Disposition 2011-09-07 200 $67.39 13,177 No 4 S Direct
Common Stock Disposition 2011-09-07 700 $68.80 12,477 No 4 S Direct
Common Stock Disposition 2011-09-07 900 $69.57 11,577 No 4 S Direct
Common Stock Disposition 2011-09-07 1,577 $70.39 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2011-09-02 4,166 $0.00 4,166 $24.00
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2011-09-06 8,334 $0.00 8,334 $24.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,664 2020-03-22 No 4 M Direct
70,836 2020-03-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 143 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 200 shares of Company stock on September 7, 2011 at prices ranging from $67.06 to $67.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 7, 2011 at each separate price.
  3. Represents volume-weighted average price of sales of 700 shares of Company stock on September 7, 2011 at prices ranging from $68.59 to $68.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 7, 2011 at each separate price.
  4. Represents volume-weighted average price of sales of 900 shares of Company stock on September 7, 2011 at prices ranging from $69.03 to $69.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 7, 2011 at each separate price.
  5. Represents volume-weighted average price of sales of 1,577 shares of Company stock on September 7, 2011 at prices ranging from $70.06 to $70.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 7, 2011 at each separate price.
  6. The stock option award (combined incentive stock option and non-qualified stock option) vests over five years, commencing one year after the date of grant. 12,500 options vest on the first anniversary, 25,000 options vest on the second anniversary, 25,000 options vest on the third anniversary, 25,000 options vest on the fourth anniversary, and 12,500 options vest on the fifth anniversary of the date of grant.
  7. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.